Concepedia

Verena Karsten

VK

10

Publications

472

Citations

10

H-Index

1992

Active since

Affiliations

Yale University(Current)

Vion Pharmaceuticals (United States)

Dana-Farber Cancer Institute

Case Western Reserve University

University School

Verena Karsten is an author at Yale University specializing in medicine, health sciences, and hematology.

Top concepts

Publications per year

1992–2009

10

Publications

10

The Protozoan Parasite <i>Toxoplasma gondii</i> Targets Proteins to Dense Granules and the Vacuolar Space Using Both Conserved and Unusual Mechanisms

Verena Karsten, Huilin Qi, Con J. Beckers et al. · The Journal of Cell Biology · 1998 · 122 citations · Full text

Cloretazine (VNP40101M), a Novel Sulfonylhydrazine Alkylating Agent, in Patients Age 60 Years or Older With Previously Untreated Acute Myeloid Leukemia

Francis G. Giles, David A. Rizzieri, Judith E. Karp et al. · Journal of Clinical Oncology · 2006 · 84 citations

Single-Agent Laromustine, A Novel Alkylating Agent, Has Significant Activity in Older Patients With Previously Untreated Poor-Risk Acute Myeloid Leukemia

Gary J. Schiller, Susan O’Brien, Arnaud Pigneux et al. · Journal of Clinical Oncology · 2009 · 74 citations · Full text

, , +20

Trypanosoma cruzi in Wild Raccoons and Opossums in North Carolina

Verena Karsten, Cheryl Davis, Raymond Kuhn · Journal of Parasitology · 1992 · 45 citations · Full text

, , +17

Phase I Study of Cloretazine (VNP40101M), a Novel Sulfonylhydrazine Alkylating Agent, Combined with Cytarabine in Patients with Refractory Leukemia

Francis J. Giles, Srđan Verstovšek, Deborah A. Thomas et al. · Clinical Cancer Research · 2005 · 34 citations · Full text

Rows per page

1–5 of 10